understanding pharmacokinetics in the microsampling revolution

Posted by Neoteryx on Feb 26, 2020 4:00:00 PM

Expert interpretation of drug concentration is critical to understanding pharmacokinetics and realizing full its clinical benefits. Clinicians achieve this by monitoring drug pharmacodynamics routinely and measuring physiological indices of therapeutic responses directly. However, the vast inter-individual variation between drug response and dosages makes it challenging to individualize drug dosage.

Read More

Topics: Clinical Trials, Immunosuppressants

3 advances in monitoring immunosuppressive agents in 2020

Posted by Neoteryx on Feb 25, 2020 7:00:00 AM

Immunosuppression prevents and treats acute rejection and graft damage during kidney transplantation. The development immunosuppressive agents such as tacrolimus, cyclosporine, and mycophenolate minimized the rejection rate and improved short-term graft survival.

Read More

Topics: Immunosuppressants

are immunosuppressive therapy drugs on the rise in 2020?

Posted by Neoteryx on Feb 24, 2020 7:00:00 AM

Over the past five decades, the medical community has witnessed considerable advancements in organ transplants. Patients receive organs, and through immunosuppressive drugs, their bodies can accept the organ.

Read More

Topics: Immunosuppressants

join the blood microsampling revolution

Posted by Neoteryx on Jan 28, 2020 3:12:00 AM

When Fasha Mahjoor launched Neoteryx, he planned to change the way dried capillary blood is collected, to become the most significant blood microsampling innovator in the modern marketplace. In that, he and his team have surely succeeded.

Read More

Topics: Clinical Diagnostics, Clinical Trials, Alternative to Dried Blood Spot, Animal Testing, Pediatrics, RNA / DNA from Dried Blood, Capillary Blood Sampling, Vet Diagnostics, Alternative to Venipuncture, Remote Patient Monitoring, Health and Wellness, Immunosuppressants

what lab managers should know about immunosuppressant monitoring

Posted by Neoteryx on Jan 23, 2020 1:23:00 AM

When using immunosuppressant drugs as an organ transplant recipient, it is crucial to effectively and consistently monitor drug levels. This requires therapeutic drug monitoring and an understanding of requirements and best practices for therapeutic drug monitoring in the laboratory.

Read More

Topics: Immunosuppressants

immunosuppressant drug monitoring: research supports microsampling

Posted by Neoteryx on Jan 14, 2020 4:43:00 AM

Therapeutic drug monitoring (TDM) for immunosuppressive drugs (ISPs) is a critical component of post-tissue and organ transplantation therapy. This is because ISP drugs have high intra- and inter-subject variability and a narrow therapeutic window. Initially, quantitative analyses of ISPs such as sirolimus, cyclosporine A, tacrolimus, and everolimus used whole blood specimens.

Read More

Topics: Alternative to Dried Blood Spot, Alternative to Venipuncture, Immunosuppressants